Search results

Refine Your Search

635724

Search Filters

Product family

Protein science [1]

Application

Technology

High capacity membrane [1]

Search results for

Available results will be divided among three tabs below.
Options for narrowing the number of matches are available on the left.

Adding terms to the "Refine Your Search" box will apply more criteria to your current results. Making selections in the "Search Filters" box will further limit your results within a variety of categories, such as application, product type, kit size, etc.

Showing 1-1 of 1 results

Capturem™ His-Tagged Purification Large Volume

Cat. #

Product

Size

License

Quantity

Details

635724

Capturem™ His-Tagged Purification Large Volume

4 Units (2 Units per box)

USD $493.00

License Statement

ID Number
273	This product is covered by U.S. Patent Nos. 9,459,188 and/or 10,207,229, exclusively licensed to Takara Bio USA, Inc.
347	This product is protected by U.S. Patents 9,895,665, 10,195,569 and foreign counterparts and/or additional U.S. and foreign patents pending. For further license information, please contact a Takara Bio USA licensing representative by email at licensing@takarabio.com.

The Capturem His-Tagged Purification Large Volume unit lets you quickly purify up to 25 mg of protein (depending on protein size and expression level) from a large volume of lysate (up to 500 ml at a time), resulting in purified protein concentrated at up to 2 mg/ml. Like our other his-tagged Capturem products, the Large Volume unit works for bacterial and mammalian expression systems with a wide range of additives. Each unit requires a minimum elution volume of 1.5 ml.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Components